Literature DB >> 27743505

Metabolite Profiling in Withania somnifera Roots Hydroalcoholic Extract Using LC/MS, GC/MS and NMR Spectroscopy.

Mahendra Kumar Trivedi1, Parthasarathi Panda2, Kalyan Kumar Sethi2, Snehasis Jana2.   

Abstract

Ashwagandha (Withania somnifera) is a very well-known herbal medicine and it was well studied for its active metabolites throughout the World. Although, nearly 40 withanolides were isolated from W. somnifera root extract, still there is remaining unidentified metabolites due to very low abundance and geographical variation. Advanced separation technology with online identification by mass and nuclear magnetic resonance (NMR) are nowadays used to find out the new compounds in the crude herbal extract. This article described the metabolite profiling of ashwagandha root hydroalcoholic extract using ultra-performance liquid chromatography coupled with a positive ion electrospray ionization tandem mass spectrometry through gas chromatography mass spectrometry (GC/MS) and NMR spectroscopy. A total of 43 possible withanolides was identified and proposed their structures based on the mass of molecular and fragment ions. GC/MS and NMR analysis indicated the presence of several known withanolides including withaferin A, withanolide D, withanoside IV or VI, withanolide sulfoxide, etc. To the best of our knowledge, dihydrowithanolide D at m/z 473 (tR 7.86 min) and ixocarpalactone A at m/z 505 (tR 8.43 min) were first time identified in the ashwagandha root hydroalcoholic extract. The current study that described the identification of withanolides with summarized literature review might be helpful for designing the experiment to identify of the new chemical constituents in Withania species.
© 2017 Wiley-VHCA AG, Zurich, Switzerland.

Entities:  

Keywords:  zzm321990Withania somniferazzm321990; Ashwagandha root extract; Retention time; Withanolides

Mesh:

Substances:

Year:  2017        PMID: 27743505     DOI: 10.1002/cbdv.201600280

Source DB:  PubMed          Journal:  Chem Biodivers        ISSN: 1612-1872            Impact factor:   2.408


  6 in total

1.  Solid and liquid state characterization of tetrahydrocurcumin using XRPD, FT-IR, DSC, TGA, LC-MS, GC-MS, and NMR and its biological activities.

Authors:  Mahendra Kumar Trivedi; Parthasarathi Panda; Kalyan Kumar Sethi; Mayank Gangwar; Sambhu Charan Mondal; Snehasis Jana
Journal:  J Pharm Anal       Date:  2020-02-15

2.  Metabolite accumulation and metabolic network in developing roots of Rehmannia glutinosa reveals its root developmental mechanism and quality.

Authors:  Yanqing Zhou; Ke Yang; Dandan Zhang; Hongying Duan; Yongkang Liu; Mengmeng Guo
Journal:  Sci Rep       Date:  2018-09-20       Impact factor: 4.379

Review 3.  Effects of Ashwagandha (Withania somnifera) on Physical Performance: Systematic Review and Bayesian Meta-Analysis.

Authors:  Diego A Bonilla; Yurany Moreno; Camila Gho; Jorge L Petro; Adrián Odriozola-Martínez; Richard B Kreider
Journal:  J Funct Morphol Kinesiol       Date:  2021-02-11

4.  Phytoconstituents of Withania somnifera unveiled Ashwagandhanolide as a potential drug targeting breast cancer: Investigations through computational, molecular docking and conceptual DFT studies.

Authors:  Hittanahallikoppal Gajendramurthy Gowtham; Mahadevamurthy Murali; Sudarshana Brijesh Singh; Chandan Shivamallu; Sushma Pradeep; C S Shivakumar; Satish Anandan; Anjana Thampy; Raghu Ram Achar; Ekaterina Silina; Victor Stupin; Joaquín Ortega-Castro; Juan Frau; Norma Flores-Holguín; Kestur Nagaraj Amruthesh; Shiva Prasad Kollur; Daniel Glossman-Mitnik
Journal:  PLoS One       Date:  2022-10-06       Impact factor: 3.752

5.  DNA damage by Withanone as a potential cause of liver toxicity observed for herbal products of Withania somnifera (Ashwagandha).

Authors:  Shazia Siddiqui; Nabeel Ahmed; Mausumi Goswami; Anindita Chakrabarty; Goutam Chowdhury
Journal:  Curr Res Toxicol       Date:  2021-02-16

Review 6.  Effects of Withania somnifera (Ashwagandha) on Stress and the Stress- Related Neuropsychiatric Disorders Anxiety, Depression, and Insomnia.

Authors:  Alex B Speers; Kadine A Cabey; Amala Soumyanath; Kirsten M Wright
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.